Relevance: GS II (Health & Governance) & GS III (Science & Technology) | Source: PIB 

1. What is the current issue?

There is a massive, dangerous global trend of people illegally buying heavy pharmaceutical injections for quick “weight loss.”

• The Administrative Action: The Drug Controller General of India (DCGI) has launched a strict nationwide crackdown against the unauthorized sale of GLP-1 drugs.
• The Core Problem: These are highly powerful prescription medicines officially approved only to treat serious illnesses like Type 2 Diabetes and severe clinical obesity. They are not meant to be used as cosmetic “diet tools” by the general public.

2. How do they work?

To understand these drugs, we must first look at how the body manages blood sugar.

GLP-1 is a natural hormone made in our intestines after we eat. GLP-1 Agonist drugs artificially copy this hormone to do three specific things in the body:

• Boosts Insulin: It forces the pancreas to release more insulin (which lowers blood sugar).
• Blocks Extra Sugar: It stops the liver from releasing unnecessary sugar into the blood.
• Slows Down Digestion: This is the main reason for weight loss. The drug keeps food in the stomach for a much longer time. This tricks the brain into feeling completely “full” all day, naturally killing the person’s appetite.
• Key Medicines to Remember: Semaglutide and Liraglutide.

3. The Public Health Risk: Why is the Government worried?

Self-medicating with these powerful drugs without a doctor’s supervision is a major public health hazard:

• Severe Organ Damage: Unsupervised use can cause severe inflammation of the pancreas, kidney injury, and even rare forms of thyroid cancer.
• Digestive Paralysis: Because the drug slows down digestion, an overdose can cause the stomach to completely stop moving food (a dangerous condition called Gastroparesis).
• Fatal Blood Sugar Drop: It can cause blood sugar levels to crash to dangerously low, life-threatening levels (Hypoglycemia).

4. The Legal and Regulatory Framework in India

To protect citizens from these side effects, the government is enforcing strict pharmaceutical laws:

• Strict Prescription Rules: GLP-1 drugs are categorized as Schedule H drugs. This means it is a criminal offense for pharmacies to sell them “Over-The-Counter” (OTC). They require a valid prescription from a specialized doctor.
• Raids and Audits: The government regulatory body (CDSCO) is actively raiding and auditing online pharmacies and unauthorized “wellness clinics” to stop illegal sales.
• Ban on Misleading Ads: The administration has strictly ordered drug manufacturers and clinics to immediately stop advertising these dangerous drugs as “miracle weight-loss injections” on social media.

UPSC Value Box

With reference to GLP-1 (Glucagon-Like Peptide-1) agonist drugs and India’s pharmaceutical regulations, consider the following statements:

1. GLP-1 drugs aid in weight loss primarily by accelerating the rate of digestion and gastric emptying.
2. Semaglutide and Liraglutide are prominent examples of GLP-1 agonist medications.
3. The Central Drugs Standard Control Organisation (CDSCO) functions as the apex drug regulatory authority under the Ministry of Health and Family Welfare.

Which of the statements given above is/are correct?

(a) 1 and 2 only

(b) 2 and 3 only

(c) 1 and 3 only

(d) 1, 2 and 3

Correct Answer: (b)